| abstract |
The present invention provides heterocyclic compounds and methods of use. The present application provides compounds for treating metabolic and hyperproliferative disorders and methods of using those compounds, comprising administering the compounds in combination with a hormone receptor antagonist. Do. The present disclosure relates generally to therapeutics for the treatment of hyperproliferative disorders, metabolic disorders, and pancreatitis. The present disclosure provides compounds for treating benign and malignant hyperproliferative disorders, as well as metabolic disorders and pancreatitis and methods of using those compounds, as described below. The compounds of the present invention may also be used in the treatment of cancer. 【Selection chart】 None |